We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Low Vitamin D Levels May Harm Heart Health

By LabMedica International staff writers
Posted on 23 Nov 2015
Vitamin D is important for bone health, promoting calcium absorption, but studies have increasingly suggested the vitamin may also play an important role in heart health, linking vitamin D deficiency to increased risk for high blood pressure, heart attack and heart disease.

Individuals who do not get enough vitamin D through dietary sources including oily fish, eggs, and supplements or sun exposure often have vitamin D deficiency as when the levels of the vitamin in the body are too low, which is determined by measuring levels of 25-hydroxyvitamin D (25-OHD) in the blood.

Scientists at the Intermountain Medical Center Heart Institute (Salt Lake City, UT, USA) assessed how vitamin D levels affected the health of more than 230,000 patients who were on their database. More...
The team allocated each patient into one of four groups dependent on their 25-OHD levels: less than 15 ng/mL, 15–29 ng/mL, 30–44 ng/mL, and more than 45 ng/mL. Over the next three years, they monitored the patients for any incidence of major cardiac events, including coronary heart disease, heart attack, stroke and heart failure, as well as incidence of kidney failure and death.

The investigators found that patients whose 25-OHD levels were less than 15 ng/mL were 35% more likely to experience a cardiovascular event in the subsequent three years than participants in the other three groups. The risk for cardiovascular events was the same for participants whose 25-OHD levels were 15–29 ng/mL, 30–44 ng/mL, or more than 45 ng/mL, according to the results. Accordingly, these findings indicate that if a person's 25-OHD levels are 15–29 ng/mL or above, they should not be concerned about the effect their vitamin D levels may have on their heart, and vitamin D supplementation is unlikely to improve heart health any further.

J. Brent Muhlestein, MD, the lead author of the study, said, “Although vitamin D levels above 30 were traditionally considered to be normal, more recently, some studies have proposed that anything above 15 was a safe level. But the numbers had not been backed up with any studies until now. Even if any level above 15 is safe, one out of 10 people still have vitamin D levels lower than that. This equates to a very large percentage of our population. The best way to determine one’s vitamin D level is by getting a blood test.” The study was presented on November 9, 2015, at the American Heart Association's Scientific Sessions held Orlando, FL, USA).

Related Links:

Intermountain Medical Center Heart Institute 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.